Company Description
Londax Corp (LDXC) is a corporation organized in the state of Wyoming and identified with Commission File Number 333-274140 and IRS Employer Identification Number 35-2807931, as disclosed in its filings with the U.S. Securities and Exchange Commission (SEC). According to these filings, Londax Corp is classified as an emerging growth company under U.S. securities regulations. The company’s principal executive offices are located in Limassol, Cyprus.
In an SEC Form 8-K, Londax Corp reported that its principal executive offices were relocated to Limassol, Cyprus. The filing also indicates that the company does not have securities registered under Section 12(b) of the Securities Exchange Act, and the table of securities registered pursuant to Section 12(b) lists "N/A" for both title of each class and trading symbol, with "NA" as the name of each exchange on which registered. This suggests that Londax Corp’s shares are not listed on a major U.S. securities exchange under Section 12(b) at the time of that filing.
As an emerging growth company, Londax Corp is eligible for certain scaled disclosure and compliance accommodations under U.S. securities laws. Its status and regulatory disclosures are documented through periodic and current reports filed with the SEC, including Forms 10-Q, 8-K, and related notices.
Regulatory and Reporting Profile
Londax Corp files reports with the SEC under the Securities Exchange Act of 1934. In its Form 12b-25 (Notification of Late Filing), the company stated that it was unable to file a quarterly report on Form 10-Q for the period ended August 31, 2025, within the prescribed time period. The company cited the need for additional time to complete its financial statements and prepare the Form 10-Q. In that notification, Londax Corp indicated that it expected to file the Form 10-Q within the additional time allowed under Rule 12b-25.
The same notification states that all other periodic reports required under Section 13 or 15(d) of the Exchange Act during the preceding 12 months, or for such shorter period that Londax Corp was required to file such reports, had been filed. The company also indicated that it did not anticipate a significant change in results of operations from the corresponding period for the last fiscal year, as reflected in the earnings statements to be included in the subject report.
Corporate Governance and Management Changes
In a Form 8-K, Londax Corp reported changes in its board and executive leadership. The filing describes the resignation of a member of the Board of Directors and the appointment of a new board member. It also notes the resignation of an interim chief executive officer and interim chief financial officer, and the appointment of a new interim chief executive officer and interim chief financial officer on the same date. The Form 8-K states that the board resignation was related to the company’s desire to reduce costs and increase internal efficiency and was not due to any disagreement regarding operations, policies, or practices.
These disclosures provide insight into Londax Corp’s governance structure and its approach to managing costs and internal processes, as reported in its official SEC filings.
Headquarters and Jurisdiction
According to the Form 8-K, Londax Corp relocated its principal executive offices from a prior location in Latvia to Limassol, Cyprus. The filing specifies the new city and country for the principal executive offices. The company’s state of incorporation is Wyoming, which is also disclosed in the same Form 8-K. This combination of a U.S. state of incorporation and principal executive offices in Cyprus is part of the company’s disclosed corporate structure.
Business Information Limitations
The SEC filings provided focus on corporate governance, reporting status, and administrative matters such as relocation of principal executive offices and filing timelines. They do not describe Londax Corp’s specific industry, operating business model, products, or services. As a result, only limited information about the company’s operations is available from these sources.
Based on the available filings, Londax Corp can be characterized as a Wyoming corporation and emerging growth company that files periodic and current reports with the SEC, has its principal executive offices in Limassol, Cyprus, and has undergone recent changes in its board and executive leadership. Details about its industry sector, revenue sources, and operational activities are not specified in the provided documents.
How Investors Use Information on Londax Corp
For Londax Corp, the most detailed publicly available information in the provided data comes from its SEC filings. Investors and researchers examining LDXC typically review documents such as Forms 8-K and 12b-25 to understand:
- The company’s legal and regulatory status as an emerging growth company.
- Changes in executive leadership and board composition.
- Relocation of principal executive offices and related corporate decisions.
- Timeliness of financial reporting and any delays in filing required reports.
Because the filings do not describe the company’s specific line of business, any assessment of Londax Corp’s operations must rely on additional disclosures beyond the scope of the documents summarized here.
Stock Performance
Londax (LDXC) stock last traded at $1.50. Over the past 12 months, the stock has gained 500.0%.
LDXC Rankings
Latest News
SEC Filings
Londax has filed 5 recent SEC filings, including 3 Form 10-Q, 2 Form 3. The most recent filing was submitted on April 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LDXC SEC filings →
Financial Highlights
Londax generated $66K in revenue over the trailing twelve months, retaining a 81.9% gross margin, operating income reached -$1K (-1.8% operating margin), and net income was -$1K, reflecting a -1.8% net profit margin. Diluted earnings per share stood at $0.00. The company generated $94K in operating cash flow. With a current ratio of 0.55, short-term liquidity bears monitoring.